AAP Grand Rounds Subscribe to Pediatrics in Review
HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Take the CME quiz:
Vol. 14 No. 4, October 2005
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dubik, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Dubik, M.
Related Collections
Right arrow Clinical Pharmacology and Therapeutics
Right arrow Emergency Medicine
Right arrow Combined Internal Medicine-Pediatrics

AAP Grand Rounds 14:41-42 (2005)
© 2005 American Academy of Pediatrics

EMERGENCY MEDICINE

Midazolam in the Bum or Between Cheek and Gum?

Source: McIntyre J, Robertson S, Norris E, et al. Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: a randomized controlled trial. Lancet. 2005;366:205–210.[Medline]

The first 20% of the full text of this article appears below.

To compare the safety and efficacy of rectal diazepam and buccal midazolam for the treatment of acute tonic-clonic seizures in children, researchers in the United Kingdom conducted a multicenter, nonblinded, randomized controlled trial. The study group included 177 patients, ages 6 months and older, representing 219 separate emergency department visits to 1 of 4 participating hospitals. Participants’ median age was 3 years (range: age 7 months to 15 years) and 98 of the 177 (55%) were male. All had visible seizure activity upon arrival in the ED, and none had established intravenous access. The dose of midazolam or diazepam was approximately 0.5 mg/kg based on estimated weight. The intravenous preparation of midazolam was dripped into the buccal cavity between the gum and cheeks using a needle or straw. Of the 219 episodes, 109 . . . [Full Text of this Article]

Mike Dubik, MD, FAAP
Pediatrics, Naval Medical Center, San Diego, CA

 






HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Academy of Pediatrics.